Ann Arbor, MI, United States of America

Theodore Standiford

This inventor holds 6 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: University of Michigan, Michigan State University. Active years: 1999-2025.

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1999-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Theodore Standiford: Pioneering Treatments Through Polymer Technology

Introduction

Theodore Standiford, an esteemed inventor based in Ann Arbor, Michigan, has made significant contributions to the field of biomedical engineering. With a portfolio consisting of six patents, Standiford has focused his efforts on developing innovative methods and treatments that address various health issues related to neutrophil function.

Latest Patents

One of Standiford's latest innovations is centered on the development of polymer particles designed to modulate neutrophil activity. These patents provide methods of treatment, compositions, systems, and kits that utilize these polymer particles to restrain neutrophil function effectively. His work showcases potential applications in preventing, treating, and ameliorating inflammatory diseases, infections, autoimmune disorders, and malignant diseases—conditions wherein neutrophils play a significant role. Furthermore, his research indicates that these polymer particles may also serve diagnostic purposes for diseases linked to neutrophil activity.

Career Highlights

Standiford has had a distinguished career, primarily working in reputable institutions such as the University of Michigan and Michigan State University. His experience in these prominent research universities has undoubtedly enriched his knowledge and skill set, enhancing his capacity to innovate effectively within the field.

Collaborations

Throughout his career, Standiford has collaborated with notable professionals, including Omolola Eniola-Adefeso and William N. Kelley. These partnerships have allowed him to combine expertise and further push the boundaries of research in neutrophil-related therapies and innovations.

Conclusion

Theodore Standiford continues to be a pivotal figure in biomedical engineering, demonstrating a commitment to improving healthcare through his innovative patents and collaborations. His focused research on polymer particles and neutrophil function not only offers promising treatment options but also paves the way for future investigations into related medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…